Sagar Lonial
Vermogen: 5 M $ op 31-07-2026
Vermogen: 5 M $ op 31-07-2026
Dr. Sagar Lonial, MD, is an Independent Director at TG Therapeutics, Inc., a Chief Medical Officer at Winship Cancer Institute and a Department Chair-Hematology & Medical Oncology at Emory University School of Medicine.
He is on the Board of Directors at TG Therapeutics, Inc. He received his doctorate degree from the University of Louisville School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-06-2026 | 94.061 ( 0,06% ) | 5 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TG THERAPEUTICS, INC. | Directeur/Bestuurslid | 29-04-2020 |
Winship Cancer Institute | Hoofd Techniek/Wetenschap/O&O | - |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
TG Therapeutics, Inc.
TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Louisville School of Medicine
University of Louisville School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Winship Cancer Institute |
Kies jouw editie
Alle financiële informatie op nationaal niveau